Key facts
- This page summarizes William J. DeLaney III's Form 4 filing for Cigna Group (CI).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Aug 2024, 17:14.
William J. DeLaney III - 19 Aug 2024 Form 4 Insider Report for Cigna Group (CI)
- Reporting relationship
- Director
- Issuer ticker
- CI
- Reported as of
- 19 Aug 2024
- Net transaction value
- -$450,974
- SEC form
- 4
- Accepted by SEC
- 21 Aug 2024, 17:14:32 UTC
- Prior SEC filing
- 02 Jul 2024
- Next SEC filing
- 03 Oct 2024
- Source filing
- View source filing
- Reporting owner signature
- Matthew Arnold, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
William J. DeLaney III filed Form 4 for Cigna Group (CI) on 21 Aug 2024.
Change
- Previous filing in this sequence was filed on 02 Jul 2024.
- Current net transaction value: -$450,974.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CI
transaction
Common Stock, $.01 Par Value
Options Exercise
- Transaction value
- $471,177
- Shares
- +2,691
- Change %
- +15%
- Price
- $175.09
- Shares after
- 20,230
- Date
- 19 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
CI
transaction
Common Stock, $.01 Par Value
Sale
- Transaction value
- -$922,152
- Shares
- -2,691
- Change %
- -13%
- Price
- $342.68
- Shares after
- 17,539
- Date
- 19 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CI
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,691
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 19 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock, $.01 Par Value
- Underlying amount
- 2,691
- Exercise price
- $175.09
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 2 footnotes
Footnote F1
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2024.
Footnote F2
These stock options were granted on May 6, 2015 and were fully vested at the closing of the acquisition of Express Scripts Holding Company on December 20, 2018.